BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37029604)

  • 1. Lateral lumbar interbody fusion - clinical outcomes, fusion rates and complications with recombinant human bone morphogenetic protein-2.
    Morton MB; Wang YY; Buckland AJ; Oehme DA; Malham GM
    Br J Neurosurg; 2023 Apr; ():1-7. PubMed ID: 37029604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion Rates of Lateral Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2.
    Nourian AA; Harrington J; Pulido PA; McCauley JC; Bruffey JD; Eastlack RK
    Global Spine J; 2019 Jun; 9(4):398-402. PubMed ID: 31218198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of L5-S1 axial lumbar interbody fusion (AxiaLIF): a comparison with and without the use of recombinant human bone morphogenetic protein-2.
    Gerszten PC; Tobler WD; Nasca RJ
    Spine J; 2011 Nov; 11(11):1027-32. PubMed ID: 22122835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcomes of lateral lumbar interbody fusion without decompression for the treatment of symptomatic degenerative spondylolisthesis at L4-5.
    Campbell PG; Nunley PD; Cavanaugh D; Kerr E; Utter PA; Frank K; Stone M
    Neurosurg Focus; 2018 Jan; 44(1):E6. PubMed ID: 29290128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up.
    Parker RM; Malham GM
    Eur Spine J; 2017 Mar; 26(3):754-763. PubMed ID: 28028645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEEK versus titanium cages in lateral lumbar interbody fusion: a comparative analysis of subsidence.
    Campbell PG; Cavanaugh DA; Nunley P; Utter PA; Kerr E; Wadhwa R; Stone M
    Neurosurg Focus; 2020 Sep; 49(3):E10. PubMed ID: 32871573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Mixture of Recombinant Human Bone Morphogenic Protein-2 and Demineralized Bone Matrix in Lateral Lumbar Interbody Fusion.
    Son JI; Lee YS; Ko MJ; Wui SH; Park SW
    J Korean Neurosurg Soc; 2024 May; 67(3):354-363. PubMed ID: 37850225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) in real world spine surgery. A phase IV, National, multicentre, retrospective study collecting data from patient medical files in French spinal centres.
    Vincentelli AF; Szadkowski M; Vardon D; Litrico S; Fuentès S; Steib JP; Le Huec JC; Huppert J; Dubois G; Lenoir T; Sailhan F; Passuti N
    Orthop Traumatol Surg Res; 2019 Oct; 105(6):1157-1163. PubMed ID: 31324520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Feasibility of Injectable Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 for Anterior Lumbar Interbody Fusion at the Lumbosacral Junction in Adult Spinal Deformity Surgery: A Clinical Pilot Study.
    Im SK; Lee JH; Lee KY; Yoo SJ
    Orthop Surg; 2022 Jul; 14(7):1350-1358. PubMed ID: 35633034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of vascular approach surgeons on perioperative complications in lateral transpsoas lumbar interbody fusions.
    Manning J; Wang E; Varlotta C; Woo D; Ayres E; Eisen L; Bendo J; Goldstein J; Spivak J; Protopsaltis TS; Passias PG; Buckland AJ
    Spine J; 2020 Mar; 20(3):313-320. PubMed ID: 31669613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive anterior and lateral transpsoas approaches for closed reduction of grade II spondylolisthesis: initial clinical and radiographic experience.
    Xu DS; Bach K; Uribe JS
    Neurosurg Focus; 2018 Jan; 44(1):E4. PubMed ID: 29290134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
    Slosar PJ; Josey R; Reynolds J
    Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of 3 surgical strategies for adult spinal deformity with mild to moderate sagittal imbalance.
    Bae J; Theologis AA; Strom R; Tay B; Burch S; Berven S; Mummaneni PV; Chou D; Ames CP; Deviren V
    J Neurosurg Spine; 2018 Jan; 28(1):40-49. PubMed ID: 29087808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Fusion Rates After Direct Lateral Lumbar Interbody Fusion With Bone-Morphogenetic Protein.
    Zhang H; Dial B; Brown C
    Int J Spine Surg; 2021 Jun; 15(3):423-428. PubMed ID: 33963022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.